Risk was highest, and almost 100% within a few years post delivery, in islet autoantibodypositive GDM women, followed by islet autoantibodynegative GDM women who required insulin therapy to manage diabetes during pregnancy, and obese islet autoantibody-negative GDM women who did not require insulin therapy during pregnancy.